{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:05:05Z","timestamp":1753887905615,"version":"3.41.2"},"reference-count":31,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz J Med Biol Res"],"DOI":"10.1590\/1414-431x2024e13278","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T13:04:09Z","timestamp":1728306249000},"source":"Crossref","is-referenced-by-count":0,"title":["Synergistic effect of venetoclax and ibrutinib on ibrutinib-resistant ABC-type DLBCL cells"],"prefix":"10.1590","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6545-9400","authenticated-orcid":false,"given":"Fengbo","family":"Jin","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Anhui Medical University,  China; Anhui Public Health Clinical Center,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5781-000X","authenticated-orcid":false,"given":"Limei","family":"He","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui Medical University,  China; Anhui Public Health Clinical Center,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5583-6241","authenticated-orcid":false,"given":"Yingying","family":"Chen","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui Medical University,  China; Anhui Public Health Clinical Center,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4539-9107","authenticated-orcid":false,"given":"Wanlu","family":"Tian","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui Medical University,  China; Anhui Public Health Clinical Center,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8588-1383","authenticated-orcid":false,"given":"Lixia","family":"Liu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui Medical University,  China; Anhui Public Health Clinical Center,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2556-693X","authenticated-orcid":false,"given":"Ling","family":"Ge","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui Medical University,  China; Anhui Public Health Clinical Center,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4216-1949","authenticated-orcid":false,"given":"Wei","family":"Qian","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui Medical University,  China; Anhui Public Health Clinical Center,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6760-0153","authenticated-orcid":false,"given":"Leiming","family":"Xia","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui Medical University,  China; Anhui Public Health Clinical Center,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9667-1583","authenticated-orcid":false,"given":"Mingzhen","family":"Yang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui Medical University,  China; Anhui Public Health Clinical Center,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel RL","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"102443","DOI":"10.1016\/j.ctrv.2022.102443","article-title":"Treatment strategies for patients with diffuse large B-cell lymphoma","volume":"110","author":"Poletto S","year":"2022","journal-title":"Cancer Treat Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.2174\/1389557522666220519085134","article-title":"Advances and challenges in the investigation of metastasis in diffuse large B-cell lymphoma","volume":"22","author":"Chen Y","year":"2022","journal-title":"Mini Rev Med Chem"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1080\/0284186X.2021.1898048","article-title":"R-CHOP compared to R-CHOP + X for newly diagnosed diffuse large B-cell lymphoma: a systematic review and meta-analysis","volume":"60","author":"Pasvolsky O","year":"2021","journal-title":"Acta Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/nm.3884","article-title":"Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma","volume":"21","author":"Wilson WH","year":"2015","journal-title":"Nat Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcv.2004.05.016","article-title":"Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR green chemistry","volume":"31","author":"Lee TH","year":"2004","journal-title":"J Clin Virol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1200\/JCO.18.02403","article-title":"Randomized phase III trial of ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in non-germinal center B-Cell diffuse large B-Cell lymphoma","volume":"37","author":"Younes A","year":"2019","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1158\/1535-7163.MCT-16-0555","article-title":"Combination of ibrutinib and ABT-199 in diffuse large B-cell lymphoma and follicular lymphoma","volume":"16","author":"Kuo HP","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00277-021-04535-7","article-title":"Ibrutinib combined with venetoclax for the treatment of relapsed\/refractory diffuse large B cell lymphoma","volume":"100","author":"Zhou Z","year":"2021","journal-title":"Ann Hematol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1073\/pnas.1921187117","article-title":"Regulation of B cell receptor-dependent NF-kappaB signaling by the tumor suppressor KLHL14","volume":"117","author":"Choi J","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"42232","DOI":"10.18632\/oncotarget.6273","article-title":"Combinatorial BTK and MALT1 inhibition augments killing of CD79 mutant diffuse large B cell lymphoma","volume":"6","author":"Nagel D","year":"2015","journal-title":"Oncotarget"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1182\/bloodadvances.2022008821","article-title":"BTK and PLCG2 remain unmutated in one third of patients with CLL relapsing on ibrutinib","volume":"7","author":"Bonfiglio S","year":"2023","journal-title":"Blood Adv"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1182\/blood-2017-10-811752","article-title":"BTK(Cys481Ser) drives ibrutinib resistance via ERK1\/2 and protects BTK(wild-type) MYD88-mutated cells by a paracrine mechanism","volume":"131","author":"Chen JG","year":"2018","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"38180","DOI":"10.18632\/oncotarget.9500","article-title":"Genetic heterogeneity in primary and relapsed mantle cell lymphomas: impact of recurrent CARD11 mutations","volume":"7","author":"Wu C","year":"2016","journal-title":"Oncotarget"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"20406207211013987","DOI":"10.1177\/20406207211013987","article-title":"Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications","volume":"12","author":"Papageorgiou SG","year":"2021","journal-title":"Ther Adv Hematol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","article-title":"Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab","volume":"28","author":"Barrans S","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1182\/blood-2013-02-483727","article-title":"Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing","volume":"122","author":"Morin RD","year":"2013","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers AJ","year":"2013","journal-title":"Nat Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1200\/JCO.2016.70.4320","article-title":"Phase I first-in-human study of venetoclax in patients with relapsed or refractory non-hodgkin lymphoma","volume":"35","author":"Davids MS","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1182\/blood.2020006578","article-title":"A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma","volume":"137","author":"Morschhauser F","year":"2021","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier B","year":"2002","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1200\/JCO.2014.60.2383","article-title":"Prognostic significance of diffuse large B-cell lymphoma cell of origin determined by digital gene expression in formalin-fixed paraffin-embedded tissue biopsies","volume":"33","author":"Scott DW","year":"2015","journal-title":"J Clin Oncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz R","year":"2018","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/jha2.517","article-title":"Ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone in patients with previously untreated non-germinal centre B-cell-like diffuse large B-cell lymphoma: A Chinese subgroup analysis of the phase III PHOENIX trial","volume":"3","author":"Zhu J","year":"2022","journal-title":"eJHaem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright GW","year":"2020","journal-title":"Cancer Cell"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1182\/asheducation-2017.1.295","article-title":"Current treatment of double hit and double expressor lymphoma","volume":"2017","author":"Reagan PM","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/leu.2017.251","article-title":"Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets","volume":"32","author":"Karube K","year":"2018","journal-title":"Leukemia"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1074\/jbc.M111.264481","article-title":"Natural diterpenoid compound elevates expression of Bim protein, which interacts with antiapoptotic protein Bcl-2, converting it to proapoptotic Bax-like molecule","volume":"287","author":"Zhao L","year":"2012","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ccr.2008.09.002","article-title":"A short Nur77-derived peptide converts Bcl-2 from a protector to a killer","volume":"14","author":"Kolluri SK","year":"2008","journal-title":"Cancer Cell"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.molcel.2012.01.030","article-title":"Differences in the mechanisms of proapoptotic BH3 proteins binding to Bcl-XL and Bcl-2 quantified in live MCF-7 cells","volume":"45","author":"Aranovich A","year":"2012","journal-title":"Mol Cell"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00204-013-1034-4","article-title":"Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis","volume":"87","author":"Sinha K","year":"2013","journal-title":"Arch Toxicol"}],"container-title":["Brazilian Journal of Medical and Biological Research"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0100-879X2024000100679&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T13:04:20Z","timestamp":1728306260000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0100-879X2024000100679&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":31,"alternative-id":["S0100-879X2024000100679"],"URL":"https:\/\/doi.org\/10.1590\/1414-431x2024e13278","relation":{},"ISSN":["1414-431X","0100-879X"],"issn-type":[{"type":"electronic","value":"1414-431X"},{"type":"print","value":"0100-879X"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e13278"}}